Narendra D. Lalwani - Net Worth and Insider Trading
Narendra D. Lalwani Net Worth
The estimated net worth of Narendra D. Lalwani is at least $8,150 dollars as of 2024-09-24. Narendra D. Lalwani is the COO of Esperion Therapeutics Inc and owns about 5,000 shares of Esperion Therapeutics Inc (ESPR) stock worth over $8,150. Details can be seen in Narendra D. Lalwani's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Narendra D. Lalwani has not made any transactions after 2016-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Narendra D. Lalwani
Narendra D. Lalwani Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Narendra D. Lalwani owns 1 companies in total, including Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Narendra D. Lalwani’s form 4 insider trades.
Insider Ownership Summary of Narendra D. Lalwani
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2016-11-01 | Chief Operating Officer |
Narendra D. Lalwani Latest Holdings Summary
Narendra D. Lalwani currently owns a total of 1 stock. Narendra D. Lalwani owns 5,000 shares of Esperion Therapeutics Inc (ESPR) as of November 1, 2016, with a value of $8,150.
Latest Holdings of Narendra D. Lalwani
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2016-11-01 | 5,000 | 1.63 | 8,150 |
Holding Weightings of Narendra D. Lalwani
Narendra D. Lalwani Form 4 Trading Tracker
According to the SEC Form 4 filings, Narendra D. Lalwani has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 5,000 shares on November 1, 2016, which cost Narendra D. Lalwani around $49,650.
Insider Trading History of Narendra D. Lalwani
- 1
Narendra D. Lalwani Trading Performance
GuruFocus tracks the stock performance after each of Narendra D. Lalwani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Narendra D. Lalwani is 33.27%. GuruFocus also compares Narendra D. Lalwani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Narendra D. Lalwani within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Narendra D. Lalwani's insider trading performs compared to the benchmark.
Performance of Narendra D. Lalwani
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.81 | | | | | |
| Relative Return to S&P 500(%) | 1.05 | | | | | |
Narendra D. Lalwani Ownership Network
Narendra D. Lalwani Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Narendra D. Lalwani is the Chief Operating Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Operating Officer Sheldon L. Koenig , Chief Commercial Officer Eric Warren , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Narendra D. Lalwani made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,687 shares made by Eric Warren , a net sale of 5,140 shares made by Joanne M. Foody , and a net purchase of 5,450 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 18,394 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,394 shares. During the past 18 months, 28,667 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 30,944 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Narendra D. Lalwani Mailing Address
Above is the net worth, insider trading, and ownership report for Narendra D. Lalwani. You might contact Narendra D. Lalwani via mailing address: 3891 Ranchero Drive, Suite 150, C/o Esperion Therapeutics, Inc., Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
